ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 720065 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 720065; 2) Community: the network communities that were significantly associated with the response to NSC 720065; 3) Molecule: the relationships between components within communities and NSC 720065; 4) MDR: the compounds that were significantly associated with the NSC 720065.

NSC Compound Enrichment Correlation
NSC 86371 Quinolinium, 2-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1,6-dimethyl- iodide 0.0174563696971636 0.34116846
NSC 102627 Yoshi 864 0.0174563696971638 0.48679991
NSC 12150 Decanediamine, N,N'-bis(4-amino-2-methyl-6-quinolinyl)-, dihydrochloride 0.0174563696971638 0.15461533
NSC 145219 Null 0.0174563696971638 0.22681115
NSC 166641 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 7-fluoro-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, monohydrochloride 0.0174563696971638 0.29662691
NSC 300288 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-[2-(dimethylamino)ethyl]-5-nitro- 0.0174563696971638 0.44564684
NSC 602613 Null 0.0174563696971638 0.41235368
NSC 606698 Rapamycin prodrug, Mono-(28)-N,N-dimethylglycinate-, methanesulfonic acid salt 0.0174563696971638 0.43045756
NSC 623902 Null 0.0174563696971638 0.38357696
NSC 626167 Aplidazole C . TFA 0.0174563696971638 0.20575548
Total:85  Current:34    [First] [Prev] [Next] [Last]